The page is the record's research on the issuer — no analyst, no rating, no view. # Cardiol Therapeutics Inc. (NASDAQ: CRDL) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Cardiol Therapeutics Inc., listed on NASDAQ under ticker CRDL with ISIN US14161Y2000. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-A6). Its security type is non-operating entity type (other), its segment is not on the record, and its sector is 2836 Biological Products, (No Diagnostic Substances). Its jurisdiction is Ontario, Canada, and its status is listed, not halted. ## The disclosure read The record holds 42 filings across 34 filing days in the window from 2025-11-08 to 2026-11-08, comprising 2 prospectus, 7 regulatory filing and 33 results filings. The median gap between filing days is 7 days. The latest filing is a results filing dated 2026-11-03, which is 5 days before the record date of 2026-11-08. The exchange median is 52 filings, a cadence gap of 6.0 days and a latency of 5.0 days across 4,359 NASDAQ issuers. The sector median is 65.5 filings, a cadence gap of 5.5 days and a latency of 4.0 days across 176 issuers in 2836 Biological Products, (No Diagnostic Substances). The issuer's 42 filings sit below the exchange median of 52 and below the sector median of 65.5. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover, as foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001702123.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/CRDL (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CRDL (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CRDL · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp